---
title: "Genrix Bio: GR1803 injection system for systemic lupus erythematosus indication approved for clinical trials"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/256710704.md"
description: "Genrix Bio announced that its GR1803 injection for systemic lupus erythematosus has been approved by the National Medical Products Administration. The product is currently under research, and the indication for GR1803 injection in relapsed/refractory multiple myeloma is in the Phase II clinical trial stage. Two BCMA×CD3 targeted antibody drugs have been conditionally approved for marketing in China, but there are currently no products for the same target indication of SLE"
datetime: "2025-09-10T09:53:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/256710704.md)
  - [en](https://longbridge.com/en/news/256710704.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/256710704.md)
generator: "portal-rs"
---

# Genrix Bio: GR1803 injection system for systemic lupus erythematosus indication approved for clinical trials

According to the Zhitong Finance APP, Genrix Bio (688443.SH) announced that it has recently received the "Notice of Approval for Drug Clinical Trials" issued by the National Medical Products Administration. The clinical trial application for the company's research product GR1803 injection for the indication of systemic lupus erythematosus has been approved.

As of the announcement disclosure date, the GR1803 injection for relapsed/refractory multiple myeloma indication is in the Phase II clinical trial stage. According to publicly available information, there are two imported BCMA×CD3 targeted antibody drugs that have been conditionally approved for marketing in China, but there are currently no products for the same target SLE indication on the market

### Related Stocks

- [688443.CN](https://longbridge.com/en/quote/688443.CN.md)

## Related News & Research

- [Trump Wants Beef Prices to Come Down, But GOP Congressman Warns Washington's Import Push Could Pull the ‘Rug Out’ From Ranchers](https://longbridge.com/en/news/297776718.md)
- [Zinc BidCo stake in Tinexta rises to 90.47% of share capital after market purchases, tender offer](https://longbridge.com/en/news/297674662.md)
- [REG - AstraZeneca PLC - AstraZeneca completes agreement for Zegfrovy](https://longbridge.com/en/news/297603898.md)
- [Cotton Futures (COTTON-F) Drops on Sep 2: Key Factors to Watch](https://longbridge.com/en/news/297729940.md)
- [Padtec completes acquisition of LEV Brasil](https://longbridge.com/en/news/297704093.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**